Evidence map›Paper›PMID 23746351›Full record

ArticleMolecular cell2013

Structural definition is important for the propagation of the yeast [PSI+] prion.

Ricardo Marchante, Michelle Rowe, Jo Zenthon, Mark J Howard, Mick F Tuite

Abstract read
In one paragraph

Article in Molecular cell, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed.

  1. Article
  2. A Prion-Like Domain in EBV EBNA1 Promotes Phase Separation and Enables SRRM1 Splicing.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2025
    Article
  3. Article
  4. Molecular basis for diversification of yeast prion strain conformation.Proceedings of the National Academy of Sciences of the United States of America · 2018
    Article
  5. Article
  6. [PSI(+)] turns 50.Prion · 2015
    Article
  7. Review
  8. Article
  9. Article
  10. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Ricardo MarchanteKent Fungal Group, School of Biosciences, University of Kent, Canterbury, Kent CT2 7NJ, UK.
Michelle Rowe
Jo Zenthon
Mark J Howard
Mick F Tuite

Funding

Wellcome TrustWellcome Trust 08199Wellcome Trust 091163
6 · The paper itself

Abstract

Prions are propagated in Saccharomyces cerevisiae with remarkable efficiency, yet we know little about the structural basis of sequence variations in the prion protein that support or prohibit propagation of the prion conformation. We show that certain single-amino-acid substitutions in the prion protein Sup35 impact negatively on the maintenance of the associated prion-based [PSI(+)] trait by combining in vivo phenotypic analysis with solution NMR structural studies. A clear correlation is observed between mutationally induced conformational differences in one of the oligopeptide repeats (R2) in the N terminus of Sup35 and the relative ability to propagate [PSI(+)]. Strikingly, substitution of one of a Gly-Gly pair with highly charged residues that significantly increase structural definition of R2 lead to a severe [PSI(+)] propagation defect. These findings offer a molecular explanation for the dominant-negative effects of such psi-no-more (PNM) mutations and demonstrate directly the importance of localized structural definition in prion propagation.

Indexed as

Amino Acid SequenceAmino Acid SubstitutionConserved SequenceElectrophoresis, Polyacrylamide GelMutationNuclear Magnetic Resonance, BiomolecularPeptide Termination FactorsPhenotypeSaccharomyces cerevisiaeSaccharomyces cerevisiae ProteinsTyrosinePeptide Termination FactorsSaccharomyces cerevisiae ProteinsSUP35 protein, S cerevisiaeTyrosine

Identifiers

PMID23746351
PMCPMC3679450

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.